Achieving 20%+ weight loss pharmaceutically changes the risk-benefit calculus for many people who previously had limited options beyond surgery
Individual timelines vary based on starting weight, adherence to treatment, lifestyle factors, and metabolic characteristics
its own terms of use state it "does not provide any medical services." The brand's terms of use call this medical group Arora Health Group
Similarly, gallbladder issues are a known risk of any rapid weight loss, whether achieved through diet, surgery, or medication
Tirzepatide is FDA-approved for adults with obesity (a BMI of 30 or more) or adults with overweight (BMI of 27 or more) who also have related health issues such as high blood pressure, obstructive sleep apnea, or type 2 diabetes